Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, October 2005, p. 1177-1183, Vol. 12, No. 10
1071-412X/05/$08.00+0 doi:10.1128/CDLI.12.10.1177-1183.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland,1 Department of Veterinary Pathobiology, Center for Veterinary Health Sciences College of Veterinary Medicine, Oklahoma State University, Stillwater, Oklahoma 74078,2 Instituto de Investigación en Recursos Cinegéticos IREC (CSIC-UCLM-JCCM), Ronda de Toledo s/n, 13005 Ciudad Real, Spain,3 Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California 95616,4 Department of Veterinary Pathology, Veterinary Teaching Hospital, University of Liverpool, Leahurst, Neston Wirral, CH64 7TE, United Kingdom,5 Department of Farm Animals, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland,6 Federal Veterinary Office, Schwarzenburgstrasse 161, 3003 Bern, Switzerland7
Received 27 March 2005/ Returned for modification 3 May 2005/ Accepted 7 July 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Anaplasma phagocytophilum infects granulocytes and causes a variety of clinical signs, including human granulocytic anaplasmosis, fever and loss of milk yield in cattle, fever in small ruminants and fever, edemas, and petechia in horses (16, 18, 23, 25).
In view of the conserved nature of the msp5 gene of Anaplasma species (24) and the recent reorganization into the same genus, immunological similarities between A. marginale and A. phagocytophilum have to be expected. It was the goal of the present study to determine whether and to what degree antibodies against A. marginale would cross-react with A. phagocytophilum, whether cross-reactivity would interfere with the specificity of the serotesting, and to further investigate this cross-reactivity on the basis of the nucleotide and protein sequence of the target antigen of the enzyme-linked immunosorbent assay (ELISA) test, the major surface protein 5 (MSP5).
| MATERIALS AND METHODS |
|---|
|
|
|---|
Experimental infection with A. marginale. A total of five calves were included in the experiment. Experiments were carried out in Oklahoma. One calf (PA489) was infected intravenously (i.v.) with an A. marginale Okeechobee isolate blood stabilate, originating from a naturally infected North American bison (2). The other four calves were infected with an A. marginale Oklahoma isolate: two animals (PA 419 and PA 404) were injected i.v. with a blood stabilate from infected cows, and two animals (PA 387 and PA 412) were infected by feeding of Dermacentor variabilis and D. andersoni ticks, respectively. All calves were tested to be negative for A. marginale by a competitive ELISA (cELISA; VMRD, Pullman, WA) and by examination of Giemsa-stained blood smears prior to experimental infection.
Experimental infection with A. phagocytophilum. Six clinically healthy Brown Swiss cattle, originating from tick-free regions of Switzerland and tested to be negative for A. phagocytophilum in an immunofluorescent antibody test (IFA, Ehrlichia equi slides, VMRD, Pullman, WA), were infected i.v. with 50 ml of whole blood collected from a cow with clinical anaplasmosis carrying a Swiss strain of A. phagocytophilum (17).
Five clinically healthy Cambridge sheep, aged 1 to 2 years, were infected i.v. with a British (Old Sourhope) strain of A. phagocytophilum by using 1 ml of a 10% dilution of blood stabilate with 10% dimethyl sulfoxide (20, 25, 26).
Four healthy 3- to 16-year-old geldings (two Thoroughbreds, one Warmbred, and one Hanoverian) and a 3- and a 17-year-old mare (one quarter horse and one standardbred), seronegative for A. phagocytophilum, were inoculated i.v. with a human isolate of A. phagocytophilum originating from Wisconsin (Webster strain [1]), cultured on HL60 cells. Each animal received 1 x 106 infected HL60 cells (18).
Serologic tests. The cELISA (VMRD, Pullman, WA), licensed for the detection of antibodies to the MSP5 of A. marginale and to the respective surface proteins of A. centrale and A. ovis, was used (8, 22). In order to increase the reproducibility for individual serum samples, one positive and negative control sample each were tested together with six and three serum samples from experimental animals, respectively. This is in excess of the number of controls suggested by the manufacturer to be included per plate. The A. marginale cELISA has been approved by the U.S. Department of Agriculture for bovines but not for other species. In the present paper, it was used to evaluate the presence of antibodies in Anaplasma species in bovine, ovine and equine species. Based on the species differences, the absolute absorbance values measured in the different species cannot directly be compared. However, decreased absorbance values in individual animals during seroconversion induced by experimental infection were considered proof for induction of antibodies competing with the monoclonal antibody (MAb) present in the test kit. For the detection of antibodies to A. phagocytophilum, an IFA (Ehrlichia equi slides; VMRD, Pullman, WA) was employed. The tests were conducted according to the manufacturer's instructions. For the cELISA, the negative controls were always in the range between 0.4 and 2.1 optical densities (wavelength, 620 nm), and the positive controls showed an inhibition of more than 30%. Additionally, we required the coefficient of variation of the negative controls within a plate to be lower than 11%. For use in IFA, serum samples were serially diluted in twofold steps starting at 1:20.
For Western blot analysis, IDE8 tick cells infected with A. marginale (Virginia isolate) (14) were collected from various passages and pooled. Cells were lysed by repeated freezing and thawing on ice. As a control, material from an uninfected tick cell culture was processed identically. The protein concentration was determined in comparison to a bovine serum albumin standard by the Bradford method (Bio-Rad protein assay, Microassay Procedure for Microtiter Plates; Bio-Rad Laboratories, Hercules, California). The material was frozen in liquid nitrogen and lyophilized in a freeze drier (Benchtop, Ismatec, Glattbrugg, Switzerland). The pellet was solubilized in sample buffer (12) and adjusted to a protein concentration of 15 mg/ml. The antigens were homogenized by forcing the material through a 0.33-mm wide needle and by sonication (Sonoplus HD 2070 ultrasonic homogenizer, Bandelin electronic GmbH & Co. KG, Berlin, Germany; four cycles, 50 V, each cycle 0.2-s sonication and 0.8-s rest; 3-mm MS 73 probe; Bandelin). Preparative Western blot analysis was performed using the equivalent of 1 mg protein under conditions described previously (13). Molecular mass standards comprised 10- to 250-kDa proteins (Precision Plus protein dual-color standards, 161-0374; Bio-Rad Laboratories, Hercules, California). Strips of two to three millimeters width were cut from the membrane and incubated in serum diluted 1:100 in blocking solution (1% [wt/vol] liquid gelatin [Nordland], 50 mM trishydroxymethylaminomethan [Fluka 93349], 100 mM NaCl [Fluka 71380], 407 µM Tween 20 [Merck-Schuchardt, Hohenbrunn, Germany, pH, 7.4 adjusted with HCl]) at room temperature overnight. Antispecies antibodies conjugated to horseradish peroxidase (Cappel) were diluted 1:300 in blocking solution and strips were incubated for two hours at room temperature. For detection of MSP5, horseradish peroxidase conjugated MAbs removed from the cELISA test kit (100x Antibody Peroxidase Conjugate) were diluted 1:40 in blocking solution, and strips were incubated overnight. After thorough washing, the strips were incubated in substrate solution (2.8 mM 4-chloro-1-naphthol [Bio-Rad Laboratories, Hercules, California], 16.7%, [vol/vol] methanol, 41.65 mM trishydroxymethylaminomethan [Fluka 93349], 166 mM NaCl [Fluka 71380], 0.05% H2O2 [Fluka 95300]) for 10 min at room temperature. Strips were repeatedly dipped in aqua bidest and dried on Whatman paper (Fisher Scientific, Wohlen, Switzerland).
Statistical analysis. Correlation of test results of the cELISA and the IFA was determined by the Spearman correlation coefficient. Results of repeated measures on individual animals at different time points were analyzed for statistically significant differences using the Wilcoxon signed rank test calculated by StatView software (version 2001; SAS Institute, Inc., Cary, NC). The hypothesis was that antibody levels after infection were higher than antibody levels at time zero (one-tailed P values). When more than two different time points were compared, the Friedman test (nonparametric repeated measures analysis of variance [ANOVA]) was used to assess whether significant differences over all time points exist before comparing individual time points with the Wilcoxon test.
The results in Fig. 1 through 4 are displayed in the form of box-plots where lower line of the box represents the 25th, the middle line the 50th and the upper line the 75th and the whiskers the 10th and 90th percentiles, respectively.
|
|
| RESULTS |
|---|
|
|
|---|
Experimental infection with A. marginale. Serum samples were collected from five calves experimentally infected with A. marginale. The increase in antibody concentration to A. marginale during the course of infection, detected by cELISA which is intended to detect antibodies to A. marginale, was paralleled by results obtained in the IFA which is intended to detect antibodies to A. phagocytophilum (Fig. 1). Test results from the cELISA and IFA showed strong correlation (Spearman's rho = 0.85, P = 0.002). Inhibition of the binding of MAbs to MSP5 in the cELISA and the antibody titers to A. phagocytophilum were significantly higher in serum samples collected after infection (P = 0.03 for both tests).
Experimental infection with A. phagocytophilum. Sera were collected from six cows before and after experimental infection with a Swiss strain of A. phagocytophilum (Fig. 2). In the IFA which is based on A. phagicytophilum antigen, the overall increase of titer was significant (P = 0.004). High titers were already observed at week 2 after infection. Between week 2 and week 10, titer values did not change significantly. A significant overall difference among time points was not detected using the cELISA (P = 0.14). However, an increase in antibody titers was observed from week zero to week four (P = 0.02), with a subsequent decrease in week 10 (P = 0.06). Positive results (inhibition of 30% and higher compared to the negative control serum provided by the manufacturer) were obtained starting at week two after infection. The highest mean inhibitory values were observed by week four. By week 10 postinfection, antibody concentrations decreased. During the course of infection, each of the six cows became cELISA positive at least at one time point. Test results from IFA and cELISA were moderately correlated with each other (rho = 0.46, P = 0.02).
|
|
To confirm that antibodies produced against A. phagocytophilum after infection cross-react with MSP5 of A. marginale, Western blot analysis was done using A. marginale antigen from tick cell cultures (Fig. 5). Both, antibodies to A. marginale and to A. phagocytophilum recognized A. marginale MSP5.
|
Analysis of MSP5 sequences previously reported in the GenBank for A. marginale (strains Florida [A49213], Havana [AAS18265], and Brazil [AAO92930]) and A. centrale (strain Israel [AAL17671]) were compared to the A. phagocytophilum homologue identified in silico using as outgroups the E. canis (strain Oklahoma [AAD40619]), E. chaffeensis (strain Arkansas [AAD40620]), and E. ruminantium (strain Palm River [AAD40617]) sequences. The results showed that the A. phagocytophilum MSP5 has a 63% to 65% similarity to other Anaplasma sequences (Table 1; Fig. 6).
|
|
Sequence alignment showed the presence of regions of homology between Anaplasma and Ehrlichia sequences, including critical cysteine residues involved protein conformation (15) (Fig. 6). Furthermore, regions of sequence identity between Anaplasma MSP5 suggest the existence of cross-reactive epitopes between these proteins in the region involved in epitope recognition by monoclonal antibody ANAF16C1 used in the cELISA test (15).
| DISCUSSION |
|---|
|
|
|---|
The competitive ELISA used in our investigations is based on a monoclonal antibody directed against A. marginale MSP5. Therefore, it can be concluded that the epitope recognized by this antibody must also be present in the representatives of the group A. phagocytophilum comb. nov. used in the present study (isolates from Switzerland, Great Britain, and Wisconsin). We suspect that the immunological cross-reactivity is not restricted to MSP5 but might include also epitopes in other proteins of A. marginale and A. phagocytophilum. Sequence homologies have also been shown for the MSP4 gene of the two pathogens (3).
Alternatively to the postulated cross-reactivity, accidental cotransmission of A. marginale with A. phagocytophilum or preinfection of experimental animals had to be suspected. However, the experimentally infected cattle originated from and were kept in an A. phagocytophilum-free region (Oklahoma). In contrast to the northeastern and northwestern United States or Europe, in Oklahoma the early-stage tick vectors (Ixodes scapularis) feed on lizards and snakes that do not become infected with A. phagocytophilum.
The sheep examined in the present study originated from and were kept in Great Britain, free of A. marginale and A. ovis. And finally, the Brown Swiss cattle came from tick-free regions of Switzerland and samples collected from these animals tested A. marginale negative upon microscopical examination of blood smears before and after experimental infection. Therefore, the probability of concurrent A. marginale infection in the experimentally infected sheep and cattle seems low. Coinfection in horses is very unlikely, as A. marginale has never been reported to infect this species. Therefore, the observation that antibodies in horses induced by A. phagocytophilum infection react with the same band of 18 kDa as a MAb to A. marginale MSP5 further supports the occurrence of immunological cross-reactivity between the MSP5 proteins of these Anaplasma species. It cannot be completely excluded that antibodies to the 18-kDa protein were induced by the HL60 cells in which the A. phagocytophilum agent had been grown. However, although no control was done using serum from a horse injected with the uninfected HL60 cells, this appears to be unlikely, as the horses were infected by intravenous injection of 106 HL60 cells only. One million HL60 cells contain less than an estimated amount of 30 µg of protein and in the absence of an adjuvant this is hardly enough to induce antibodies against cellular components.
Our observations have important implications for the A. marginale and A. phagocytophilum serotesting. Positive results from serological A. marginale or A. phagocytophilum tests may result from infection with either the respective agent or a cross-reactive pathogen. This is especially important in domestic and wild ruminants that are susceptible to both agents, such as cattle, and especially in regions where both agents might be present. In these cases, we recommend very careful interpretation of the results obtained by the cELISA. A negative result suggests absence of A. marginale infection or a transient period with a very low A. marginale load. A positive result can be caused by A. marginale or A. phagocytophilum infection. Differentiation can be attempted by testing for antibodies to A. phagocytophilum. If the latter test is negative, the animal is most likely infected by A. marginale, A. centrale, or A. ovis. If the A. phagocytophilum test yields also a positive result, further differentiation should be attempted, e.g., by PCR testing of whole blood samples for the respective agents.
Knowledge of the reported cross-reactivity may prove useful for diagnostic of equine and canine samples. The cELISA could be considered for the detection of A. phagocytophilum infection in horses and dogs. However, first an evaluation needs be performed in order to define the species-specific baseline.
In view of the still limited information on nucleotide sequences and antigenic structures of many infectious agents and the ongoing/recent reorganization of the genus Anaplasma, the cross-reactivity observed between A. marginale and A. phagocytophilum may also be expected between other agents of this genus. This should be considered in any positive test where the nature of the infectious agent is unknown.
In conclusion, the immunologic cross-reactivity between A. marginale and A. phagocytophilum reported herein restricts the diagnostic efficacy of the A. marginale cELISA and the A. phagocytophilum IFA especially in species that are susceptible to both pathogens. Serodiagnosis may be considered indicative for a certain infection if only one of the two assays tests positive. If a sample tests positive in both assays, the nature of the infection must be further investigated, e.g., by PCR.
| ACKNOWLEDGMENTS |
|---|
We are indebted to J. Schmidt for support. The expert technical support by E. Rogg, E. Rhiner, M. Nussbaumer, T. Meili-Prodan, and E. Gönczi is acknowledged. We thank C. Juhls, B. Willi, and M. A. Gomes Keller for helpful discussions. Further thanks go to M. Malanga, A. Metzler, A. Hehl, and A. Kipar.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |